Cantitate/Preț
Produs
Total produse
Vezi coșul
Drug-Induced Lung Injury de Masayuki Hanaoka

Drug-Induced Lung Injury: Respiratory Disease Series: Diagnostic Tools and Disease Managements

Editat de Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba
en Limba Engleză Hardback – 31 oct 2017
This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. 

Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.

Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 64531 lei  38-44 zile
  Springer Nature Singapore – 8 ian 2019 64531 lei  38-44 zile
Hardback (1) 68353 lei  3-5 săpt.
  Springer Nature Singapore – 31 oct 2017 68353 lei  3-5 săpt.

Din seria Respiratory Disease Series: Diagnostic Tools and Disease Managements

  • 5% Chronic Obstructive Pulmonary Disease: A Systemic Inflammatory Disease
    Preț: 123500 lei
  • 5% Acute Respiratory Distress Syndrome: Advances in Diagnostic Tools and Disease Management
    Preț: 63832 lei
  • 5% Pulmonary Tuberculosis and Its Prevention
    Preț: 68647 lei
  • 5% Influenza: Advances in Diagnosis and Management
    Preț: 98078 lei
  • 5% Malignant Pleural Mesothelioma: Advances in Pathogenesis, Diagnosis, and Treatments
    Preț: 59395 lei
  • 5% Clinical Relevance of Genetic Factors in Pulmonary Diseases
    Preț: 66203 lei
  • 5% Disaster and Respiratory Diseases
    Preț: 65532 lei
  • 5% Advances in Asthma: Pathophysiology, Diagnosis and Treatment
    Preț: 44387 lei
  • 5% Aspiration Pneumonia: The Current Clinical Giant for Respiratory Physicians
    Preț: 70536 lei
  • 5% Structure-Function Relationships in Various Respiratory Systems: Connecting to the Next Generation
    Preț: 65864 lei

Preț: 68353 lei

Preț vechi: 71950 lei
-5% Nou

Puncte Express: 1025
Preț estimativ în valută:
13082€ • 13890$ • 10837£

Carte disponibilă

Livrare economică 04-18 decembrie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811044656
ISBN-10: 9811044651
Pagini: 204
Ilustrații: VIII, 215 p. 53 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.51 kg
Ediția:1st ed. 2018
Editura: Springer Nature Singapore
Colecția Springer
Seria Respiratory Disease Series: Diagnostic Tools and Disease Managements

Locul publicării:Singapore, Singapore

Cuprins

Part I　Definition, Pathogenesis, and Epidemiology.- 1. Definition, Pathogenesis and Epidemiology: What is DLI?.- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI?.- 3. Clinical Characteristics of DLI: What are the clinical features of DLI?.- Part II　Diagnosis.- 4. Diagnostic Approach for DLI: How is DLI diagnosed?.- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI?.- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted?.- 7. Pathology of DLI: What is the pathological significance of DLI?.- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI?.- Part II　Treatment.- 9. Therapeutic Strategies for DLI: How should DLI be treated?.- Part IV　Drugs Causing DLI.- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs?.- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs?.- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs?.- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines?.- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.

Notă biografică

Editors

Masayuki Hanaoka
First Department of Medicine
Shinshu University School of Medicine
Matsumoto, Japan

Hiroyuki Nakamura
Department of Respiratory Medicine
Tokyo Medical University Ibaraki Medical Center
Ibaraki, Japan

Kazutetsu Aoshiba
Department of Respiratory Medicine
Tokyo Medical University Ibaraki Medical Center
Ibaraki, Japan

Caracteristici

Introduces representative drugs causing the disorder such as antineoplastic drugs, biological products, and molecular target drugs Will not only benefit respiratory physicians but all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists Fosters a deeper understanding of the disorder, highlights the current challenges and paves the way for future clinical research